Download Citation
Article Source:
A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial
Okitsu SL,
Silvie O,
Westerfeld N,
Curcic M,
Kammer AR,
et al.
(2007)
A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial.
PLOS ONE 2(12): e1278.
https://doi.org/10.1371/journal.pone.0001278